Articles

Poll

Podcasts

Slideshows

Videos

Endocrinology

The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.

From uncovering new benefits of semaglutide to targeting hypercortisolism in people with type 2 diabetes, here are 5 key updates from the annual meeting.

HCPLive Five at ADA Scientific Sessions 2025

Verma discussed how recent advances in the field affect clinician management of  type 2 diabetes and peripheral artery disease.

Expanding the Armamentarium for T2D and PAD With Semaglutide, with Subodh Verma, MD, PhD

Verma discussed how new data from the STRIDE trial support the role of GLP-1 RAs as protective vascular medications.

New Data Supports Protective Vascular Effects of Semaglutide in T2D and PAD, with Subodh Verma, MD, PhD

This recap highlights data on stem cell-derived therapies for type 1 diabetes, cortisol-modulating strategies for hard-to-treat type 2 diabetes, and a novel once-weekly insulin alternative that matches daily injections in efficacy.

ADA 2025 Recap: 7 Trials to Know

Read the latest pivotal data on once-monthly injectables, oral GLP-1 agonists, and novel co-agonist therapies from ADA.

ADA 2025 Recap: 5 Studies on Obesity to Know

Explore the urgent need for diabetes specialists and the American College of Diabetology's efforts to enhance care through education and certification.

Diabetes Dialogue: Addressing America's Shortage of Diabetes Care Providers, with Jay Shubrook, DO, & Conan Tu, MD

Hosts sit down for a deep dive into The Diabetes Collective and what it's like operating a diabetes clinic in the modern healthcare landscape.

Diabetes Dialogue: The Diabetes Collective, with Rachael Sood, RN, MSN, APRN

A recent cross-sectional analysis has estimated the size of the American population with both MASLD and T2DM eligible for treatment.

Roughly 8 Million US Adults May be Eligible for Resmetirom Treatment for MASH

Verma went over the STRIDE trial evaluating the GLP-1 RA and its latest findings presented at ADA Scientific Sessions.

Semaglutide Offers Functional and Vascular Gains in PAD and T2D, with Subodh Verma, MD, PhD

Li and Shao discussed the heavy disease burden of type 2 diabetes in the VA population and outlined the VA MOVE! study.

Type 2 Diabetes